Key facts
- It has raised $350K across 1 recorded rounds; the latest was Seed Round ($250K) in Oct 2025.
- Aromha has filed 2 Form Ds with the SEC, most recently Oct 2025 ($250K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Aromha
Funding rounds
1 roundsAbout Aromha
Provider of an at-home brain health screening test intended to identify early signs of cognitive decline via remote smell and olfactory assessment. The company offers a brain health test, which includes odor identification, discrimination, memory and intensity assessments delivered through mailed odor cards and a web app, enabling users to detect olfactory dysfunction possibly associated with Alzheimer's, Parkinson's, and related brain disorders earlier, gain personalized insights, and take proactive steps in brain health.
- Sector
- Healthcare
- HQ
- Potomac, MD, United States
- Founded
- 2020
- Employees
- 3
- Website
- aromha.com/
- Ownership
- Privately Held (backing)
Aromha doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aromha shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aromha in its N-PORT filings yet. We sweep new filings monthly.